Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-03
V
Vivek Yadala
Assistant Professor
Also affiliated: Albert Einstein College of Medicine (2018); Westchester Medical Center (2016); Apollo Hospitals (2015); University of Arkansas Medical Center (2018); Apollo Hospitals (2015); Children's Hospital at Montefiore (2018); Edwards Comprehensive Cancer Center (2022–2023); Apollo Hospitals (2015); Marshall University (2020–2023)
COM | Internal Med Hem-Onc
4 h-index
24 pubs
107 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Vivek Yadala, Assistant Professor in the Department of Internal Medicine, Division of Hematology-Oncology at the University of Arkansas for Medical Sciences, investigates various aspects of disease mechanisms and treatment outcomes. His research has explored neurological recovery in premature infants following intraventricular hemorrhage, examining the effects of AMPA-Kainate receptor inhibition and glycogen synthase-kinase-3β inhibition on myelination. Yadala has also documented and analyzed rare medical presentations, including immunotherapy-induced sarcoid-like reactions, thymolipoma, breast cancer in patients with Birt-Hogg-Dubé syndrome, cyclic thrombocytopenia, and subcutaneous panniculitis-like T-cell lymphoma. His work contributes to the understanding of disease manifestations and potential therapeutic interventions across a range of conditions.
Metrics
- h-index: 4
- Publications: 24
- Citations: 107
Positions
-
Assistant Professor publications 2018–2026University of Arkansas for Medical Sciences COM | Internal Med Hem-Onc Institutional directory
Selected Publications
-
POSTER: CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice (2026)
-
CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice (2026)
-
MM-561: Dual-Target CAR-T and in Vivo Platforms in Relapsed/Refractory Multiple Myeloma: A Systematic Scoping Review of Efficacy, Toxicity, and Access (2026)
-
Uterine cancer mortality and demographic disparities in the United States in relation to female obesity. (2026)
-
Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr (2025)
Collaboration Network
Top Collaborators
Manpreet Saini
University of Arkansas for Medical Sciences
4 shared publications
In database
- Uterine cancer mortality and demographic disparities in the United States in relation to female obesity.
- MM-561: Dual-Target CAR-T and in Vivo Platforms in Relapsed/Refractory Multiple Myeloma: A Systematic Scoping Review of Efficacy, Toxicity, and Access
- CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
- POSTER: CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
Haritha Gandicheruvu
Sinai Hospital (US)
3 shared publications
- MM-561: Dual-Target CAR-T and in Vivo Platforms in Relapsed/Refractory Multiple Myeloma: A Systematic Scoping Review of Efficacy, Toxicity, and Access
- CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
- POSTER: CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
Tamara Al-Naimi
University of Arkansas for Medical Sciences
2 shared publications
In database
- CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
- POSTER: CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
Jowan Al‐Nusair
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Yury Kachynski
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Ihab Tahboub
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Abraham Titus
University of South Alabama (US)
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Alexander Burbelo
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Christopher Potts
Marshall University (US)
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Samhitha Gundakaram
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Thomas W. Wright
Marshall University (US)
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Muhammad Jamil
1 shared publication
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Fnu Deeksha
Post Graduate Institute of Medical Education and Research (IN)
1 shared publication
- Uterine cancer mortality and demographic disparities in the United States in relation to female obesity.
Muhammad Azan Gill
1 shared publication
- MM-561: Dual-Target CAR-T and in Vivo Platforms in Relapsed/Refractory Multiple Myeloma: A Systematic Scoping Review of Efficacy, Toxicity, and Access
Similar Researchers
Based on overlapping research topics
Erika Horta
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Disease Mechanisms Research
Cancer Treatment and Pharmacology
Sandra E. Pruitt
University of Arkansas for Medical Sciences
Medical Case Reports
Disease Mechanisms Research
Immune Response and Inflammation
L Ewing
University of Arkansas for Medical Sciences
Medical Case Reports
Disease Mechanisms Research
Immune Response and Inflammation
Chirag Sunil Lalwani
University of Arkansas at Little Rock
Neurological disorders and treatments
Medical Case Reports
Disease Mechanisms Research
Corayma Hernandez
University of Arkansas for Medical Sciences
Medical Case Reports
Disease Mechanisms Research
Immune Response and Inflammation
Srinivas Ayyadevara
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Disease Mechanisms Research
Cancer Treatment and Pharmacology